These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36644121)

  • 1. The Comparison of Gender Dysphoria, Body Image Satisfaction and Quality of Life Between Treatment-Naive Transgender Males With and Without Polycystic Ovary Syndrome.
    Gezer E; Piro B; Cantürk Z; Çetinarslan B; Sözen M; Selek A; Polat Işik A; Seal LJ
    Transgend Health; 2022 Nov; 7(6):514-520. PubMed ID: 36644121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyzing body dissatisfaction and gender dysphoria in the context of minority stress among transgender adolescents.
    Brecht A; Bos S; Ries L; Hübner K; Widenka PM; Winter SM; Calvano C
    Child Adolesc Psychiatry Ment Health; 2024 Mar; 18(1):30. PubMed ID: 38431595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Two Measures of Gender Dysphoria/Incongruence in Transgender and Cisgender Populations in China.
    Li Y; Zheng L
    Arch Sex Behav; 2023 Apr; 52(3):1019-1030. PubMed ID: 36596906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperandrogenism-related metabolic changes in drug-naïve transmen compared to cisgender women: a case-controlled study.
    Erel P; Elbasan O; Yorguner N; İmre E; Üstay Ö
    Endokrynol Pol; 2023 Aug; ():. PubMed ID: 37577993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Gender Dysphoria by Gender and Age in Japan: A Population-Based Internet Survey Using the Utrecht Gender Dysphoria Scale.
    Oshima Y; Matsumoto Y; Terada S; Yamada N
    J Sex Med; 2022 Jul; 19(7):1185-1195. PubMed ID: 35431150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utrecht Gender Dysphoria Scale - Gender Spectrum (UGDS-GS): Construct validity among transgender, nonbinary, and LGBQ samples.
    McGuire JK; Berg D; Catalpa JM; Morrow QJ; Fish JN; Nic Rider G; Steensma T; Cohen-Kettenis PT; Spencer K
    Int J Transgend Health; 2020; 21(2):194-208. PubMed ID: 33015669
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
    Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
    Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.
    Santoro N; Eisenberg E; Trussell JC; Craig LB; Gracia C; Huang H; Alvero R; Casson P; Christman G; Coutifaris C; Diamond M; Jin S; Legro RS; Robinson RD; Schlaff WD; Zhang H;
    Hum Reprod; 2016 Oct; 31(10):2268-79. PubMed ID: 27402910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood.
    Tay CT; Hart RJ; Hickey M; Moran LJ; Earnest A; Doherty DA; Teede HJ; Joham AE
    BMC Med; 2020 Dec; 18(1):389. PubMed ID: 33302955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy.
    Silva ED; Fighera TM; Allgayer RM; Lobato MIR; Spritzer PM
    Front Psychiatry; 2021; 12():621075. PubMed ID: 34381383
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender diversity in adolescents with polycystic ovary syndrome.
    Schweisberger CL; Hornberger L; Barral R; Burke C; Paprocki E; Sherman A; Vanden Brink H; Burgert TS
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1422-1428. PubMed ID: 36198004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY; Guo CX; Zhu FF; Qu PP; Lin WJ; Xiong J
    Arch Gynecol Obstet; 2013 Mar; 287(3):525-31. PubMed ID: 23108387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life in Infertile Women with Polycystic Ovary Syndrome: a Comparative Study.
    Naumova I; Castelo-Branco C; Kasterina I; Casals G
    Reprod Sci; 2021 Jul; 28(7):1901-1909. PubMed ID: 33215316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Health-Related Quality of Life in Patients with Idiopathic Hirsutism Compared to Patients with Polycystic Ovary Syndrome.
    Canat MM; Erhan H; Turkkan CY; Canat D; Ozel A; Ozturk FY; Altuntas Y
    Sisli Etfal Hastan Tip Bul; 2023; 57(3):332-338. PubMed ID: 37900345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Arch Gynecol Obstet; 2016 Feb; 293(2):447-56. PubMed ID: 26408006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.